WO2000054046A3 - Universal protein array system - Google Patents
Universal protein array system Download PDFInfo
- Publication number
- WO2000054046A3 WO2000054046A3 PCT/US2000/006244 US0006244W WO0054046A3 WO 2000054046 A3 WO2000054046 A3 WO 2000054046A3 US 0006244 W US0006244 W US 0006244W WO 0054046 A3 WO0054046 A3 WO 0054046A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- arrays
- array system
- universal protein
- protein array
- universal
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/0061—The surface being organic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00639—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium
- B01J2219/00641—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium the porous medium being continuous, e.g. porous oxide substrates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00725—Peptides
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00921374A EP1159615A2 (en) | 1999-03-10 | 2000-03-10 | Universal protein array system |
CA002365431A CA2365431A1 (en) | 1999-03-10 | 2000-03-10 | Universal protein array system |
AU41705/00A AU773291B2 (en) | 1999-03-10 | 2000-03-10 | UPA, a universal protein array system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12358699P | 1999-03-10 | 1999-03-10 | |
US60/123,586 | 1999-03-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000054046A2 WO2000054046A2 (en) | 2000-09-14 |
WO2000054046A3 true WO2000054046A3 (en) | 2000-12-21 |
Family
ID=22409568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/006244 WO2000054046A2 (en) | 1999-03-10 | 2000-03-10 | Universal protein array system |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1159615A2 (en) |
AU (1) | AU773291B2 (en) |
CA (1) | CA2365431A1 (en) |
WO (1) | WO2000054046A2 (en) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6576478B1 (en) | 1998-07-14 | 2003-06-10 | Zyomyx, Inc. | Microdevices for high-throughput screening of biomolecules |
US6780582B1 (en) | 1998-07-14 | 2004-08-24 | Zyomyx, Inc. | Arrays of protein-capture agents and methods of use thereof |
US6406921B1 (en) | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
US6682942B1 (en) | 1998-07-14 | 2004-01-27 | Zyomyx, Inc. | Microdevices for screening biomolecules |
US20020048823A1 (en) * | 2000-08-11 | 2002-04-25 | Qianjin Hu | Methods and universal monoclonal antibody array |
AUPR005600A0 (en) * | 2000-09-12 | 2000-10-05 | University Of Sydney, The | Diagnostic assay |
GB0022978D0 (en) * | 2000-09-19 | 2000-11-01 | Oxford Glycosciences Uk Ltd | Detection of peptides |
WO2002025288A2 (en) | 2000-09-22 | 2002-03-28 | Clontech Laboratories Inc. | Highly sensitive proteomic analysis methods and kits and systems for practicing the same |
DE10054055A1 (en) | 2000-10-31 | 2002-05-23 | Nmi Univ Tuebingen | Methods for analyzing proteins |
DE60141171D1 (en) | 2000-11-27 | 2010-03-11 | Intelligent Medical Devices Ll | CLINICAL INTELLIGENT DIAGNOSTIC DEVICES AND METHOD |
JP4880188B2 (en) | 2001-01-23 | 2012-02-22 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | Nucleic acid programmed protein array |
US7332286B2 (en) | 2001-02-02 | 2008-02-19 | University Of Pennsylvania | Peptide or protein microassay method and apparatus |
DE10118774A1 (en) * | 2001-04-17 | 2002-10-31 | Jerini Ag | Method for determining the substrate specificity of an enzymatic activity and device therefor |
US8148141B2 (en) | 2001-05-07 | 2012-04-03 | Hipep Laboratories | Peptide-immobilized substrate and method for measuring target protein |
US7981842B2 (en) * | 2001-06-08 | 2011-07-19 | Panomics, Inc. | Method for detecting transcription factor-protein interactions |
EP1279963A1 (en) * | 2001-07-27 | 2003-01-29 | Université de Nantes | Protein-target screening method using near-infrared fluorescent dyes |
JP4768224B2 (en) | 2001-09-10 | 2011-09-07 | メソ スケイル テクノロジーズ,エルエルシー | Method and apparatus for performing multiple measurements on one sample |
AU2002348289A1 (en) * | 2001-11-19 | 2003-06-10 | Protometrix, Inc. | Method of using a non-antibody protein to detect and measure an analyte |
GB0200617D0 (en) * | 2002-01-11 | 2002-02-27 | Oxford Glycosciences Uk Ltd | Characterisation of analytes |
GB0205910D0 (en) * | 2002-03-13 | 2002-04-24 | Sense Proteomic Ltd | Arrays and methods |
US7460960B2 (en) | 2002-05-10 | 2008-12-02 | Epitome Biosystems, Inc. | Proteome epitope tags and methods of use thereof in protein modification analysis |
US7618788B2 (en) | 2002-05-10 | 2009-11-17 | Millipore Corporation | Proteome epitope tags and methods of use thereof in protein modification analysis |
GB2402131A (en) * | 2003-03-13 | 2004-12-01 | Sense Proteomic Ltd | Early entry |
US20040209262A1 (en) * | 2003-04-21 | 2004-10-21 | Bass Jay K. | Biopolymeric arrays comprising test probes for two or more different species and methods for using the same |
EP1711819A4 (en) | 2003-12-15 | 2008-04-16 | Univ Pennsylvania Ct For Techn | Method and devices for running reactions on a target plate for maldi mass spectrometry |
KR100690948B1 (en) | 2004-06-17 | 2007-03-09 | 한국과학기술원 | Method for Cell Surface Display of Target Proteins Using FadL of E. coli |
CN1312293C (en) * | 2004-11-08 | 2007-04-25 | 博奥生物有限公司 | High flux biochip and application thereof |
KR100784261B1 (en) | 2006-01-02 | 2007-12-11 | 한국과학기술원 | Method for Cell Surface Displaying of Target Proteins Using Bacillus anthracis Exosporium |
US7855057B2 (en) | 2006-03-23 | 2010-12-21 | Millipore Corporation | Protein splice variant/isoform discrimination and quantitative measurements thereof |
US8178316B2 (en) | 2006-06-29 | 2012-05-15 | President And Fellows Of Harvard College | Evaluating proteins |
JP2009543862A (en) | 2006-07-14 | 2009-12-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Cancer biomarkers and methods of use thereof |
DK3255146T3 (en) | 2009-03-16 | 2019-08-19 | Pangu Biopharma Ltd | Compositions and Methods comprising Histidyl-tRNA Synthetase Splicing Variants with Non-Canonical Biological Activities |
US20100310576A1 (en) | 2009-03-31 | 2010-12-09 | Adams Ryan A | COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES |
US8980253B2 (en) | 2010-04-26 | 2015-03-17 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase |
US20120003639A1 (en) | 2010-04-27 | 2012-01-05 | Prelude, Inc. | Cancer biomarkers and methods of use thereof |
CN103096911B (en) | 2010-04-27 | 2018-05-29 | Atyr 医药公司 | Treatment relevant with the protein fragments of Isoleucyl-tRNA synthetase, diagnosis and the innovation of antibody compositions are found |
AU2011248489B2 (en) | 2010-04-28 | 2016-10-06 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl tRNA synthetases |
EP2563383B1 (en) | 2010-04-29 | 2017-03-01 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
CN103097523B (en) | 2010-04-29 | 2016-09-28 | Atyr医药公司 | The innovation for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Asparaginyl-tRNA synthetase finds |
WO2011150279A2 (en) | 2010-05-27 | 2011-12-01 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases |
CA2800557A1 (en) | 2010-04-29 | 2011-11-03 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy |
EP2566496B1 (en) | 2010-05-03 | 2018-02-28 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases |
CA2797277C (en) | 2010-05-03 | 2021-02-23 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases |
US9034321B2 (en) | 2010-05-03 | 2015-05-19 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases |
CA2798139C (en) | 2010-05-04 | 2019-09-24 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
CN103200953B (en) | 2010-05-14 | 2017-02-15 | Atyr 医药公司 | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
CN103096914B (en) | 2010-05-17 | 2015-08-12 | Atyr医药公司 | The innovation of the treatment relevant to the protein fragments of Leucyl-tRNA synthetase, diagnosis and antibody compositions finds |
AU2011261486B2 (en) | 2010-06-01 | 2017-02-23 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-tRNA synthetases |
EP2593125B1 (en) | 2010-07-12 | 2017-11-01 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
CN103108650A (en) | 2010-08-25 | 2013-05-15 | Atyr医药公司 | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases |
EP2714927B1 (en) | 2011-06-01 | 2016-08-10 | Medical Prognosis Institute A/S | Methods and devices for prognosis of cancer relapse |
KR20140123571A (en) | 2012-02-16 | 2014-10-22 | 에이티와이알 파마, 인코포레이티드 | Histidyl-trna synthetases for treating autoimmune and inflammatory diseases |
WO2014085434A1 (en) | 2012-11-27 | 2014-06-05 | Pontificia Universidad Catolica De Chile | Compositions and methods for diagnosing thyroid tumors |
WO2014195032A1 (en) | 2013-06-07 | 2014-12-11 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients |
EP3169815B1 (en) | 2014-07-15 | 2020-12-23 | Ontario Institute For Cancer Research | Methods and devices for predicting anthracycline treatment efficacy |
US11543411B2 (en) | 2014-12-05 | 2023-01-03 | Prelude Corporation | DCIS recurrence and invasive breast cancer |
ES2913294T3 (en) | 2015-08-28 | 2022-06-01 | Univ Columbia | Systems and procedures for matching cancer signatures |
WO2017040315A1 (en) | 2015-08-28 | 2017-03-09 | The Trustees Of Columbia University In The City Of New York | Virtual inference of protein activity by regulon enrichment analysis |
WO2020056338A1 (en) | 2018-09-14 | 2020-03-19 | Prelude Corporation | Method of selection for treatment of subjects at risk of invasive breast cancer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0063810A1 (en) * | 1981-04-29 | 1982-11-03 | Ciba-Geigy Ag | New devices and kits for immunological analysis |
EP0818467A2 (en) * | 1996-07-12 | 1998-01-14 | Nec Corporation | Aligned peptide array and a rational and rapid method for the detection of a binding or interaction site of a protein by using the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6406921B1 (en) * | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
-
2000
- 2000-03-10 AU AU41705/00A patent/AU773291B2/en not_active Ceased
- 2000-03-10 CA CA002365431A patent/CA2365431A1/en not_active Abandoned
- 2000-03-10 EP EP00921374A patent/EP1159615A2/en not_active Withdrawn
- 2000-03-10 WO PCT/US2000/006244 patent/WO2000054046A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0063810A1 (en) * | 1981-04-29 | 1982-11-03 | Ciba-Geigy Ag | New devices and kits for immunological analysis |
EP0818467A2 (en) * | 1996-07-12 | 1998-01-14 | Nec Corporation | Aligned peptide array and a rational and rapid method for the detection of a binding or interaction site of a protein by using the same |
Non-Patent Citations (4)
Title |
---|
E. ADACHI ET AL.: "Assembly process of 2D protein arrays in wetting films.", ADVANCES IN BIOPHYSICS, vol. 34, 1997, Japan, pages 81 - 92 * |
H. GE: "UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions.", NUCLEIC ACID RESEARCH, vol. 28, no. 2, 15 January 2000 (2000-01-15), Bethesda MD USA, pages e3 * |
MEDLINE, Washington DC USA; abstract no. 20075324, abstract * |
MEDLINE, Washington DC USA; abstract no. 97348061, abstract * |
Also Published As
Publication number | Publication date |
---|---|
CA2365431A1 (en) | 2000-09-14 |
EP1159615A2 (en) | 2001-12-05 |
AU773291B2 (en) | 2004-05-20 |
AU4170500A (en) | 2000-09-28 |
WO2000054046A2 (en) | 2000-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000054046A3 (en) | Universal protein array system | |
CA2294516A1 (en) | Ikk-.beta. proteins, nucleic acids and methods | |
WO2001012659A3 (en) | Human dna sequences | |
WO2002002783A3 (en) | Expression vectors | |
WO2000006737A8 (en) | Streptococcus pneumoniae proteins and nucleic acid molecules | |
AU6042699A (en) | Assays for measuring nucleic acid binding proteins and enzyme activities | |
WO1998021343A8 (en) | Genes encoding telomerase proteins | |
WO2002055684A3 (en) | Synthetic proteins containing a protein transduction domain | |
WO2007027906A3 (en) | Reagents for the detection of protein phosphorylation in leukemia signaling pathways | |
WO2002062999A3 (en) | Proteins and nucleic acids encoding same | |
WO1999006557A3 (en) | Mammalian cell membrane proteins; related reagents | |
CA2336261A1 (en) | Cyclin e2 genes and proteins | |
CA2294566A1 (en) | Ikk-.alpha. proteins, nucleic acids and methods | |
WO2003016551A3 (en) | Novel salicylic acid-binding protein encoding nucleic acid, sabp2, and methods of use thereof | |
WO2003062453A3 (en) | Polycystic kidney disease nucleic acids and proteins | |
CA2495529A1 (en) | Noonan syndrome gene | |
WO2000024771A3 (en) | Nucleic acids encoding osteoprotegerin-like proteins and methods of using same | |
AU6386399A (en) | Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses | |
WO2002063009A8 (en) | Lp mammalian proteins; related reagents | |
AU5245399A (en) | T cell receptor proteins, nucleic acid molecules, and uses thereof | |
EP1790730A3 (en) | Streptococcus pneumoniae proteins and nucleic acid molecules | |
AU2002258617A1 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
AU2001253804A1 (en) | Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof | |
EP0882796A3 (en) | Nucleic acid molecules encoding Streptococcus pneumoniae rnc protein, and compositions comprising the same | |
AU6094100A (en) | Fc epsilon receptor-luminescence inducing protein chimeric nucleic acid molecules, fusion proteins and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2365431 Country of ref document: CA Ref country code: CA Ref document number: 2365431 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000921374 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09936005 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000921374 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |